IP Library Granted Patent US 12,383,168
Granted Patent B2
US 12,383,168 · App. 18/624,350 · Granted Aug 12, 2025

Insulin pump based expert system

Inventor: Michael Blomquist (Blaine, MN)
Assignee: Tandem Diabetes Care, Inc
A61B5/14532A61B5/4839A61B5/7475A61M5/1723G16H10/20G16H20/17G16H40/63G16H40/67G16H50/20A61B5/7275A61B2560/045A61M2005/14208A61M2205/3561A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,383,168
App. No.
18/624,350
Granted
Aug 12, 2025
Kind
B2
Abstract

An apparatus comprising a pump configured to deliver insulin, an input configured to receive blood glucose data, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a blood glucose data module to compare the blood glucose data to a target blood glucose level for an insulin pump user. The controller is configured to present a question related to the blood glucose level via the user interface when the blood glucose level is different than the target blood glucose level, receive a response to the question via the user interface, and present a recommended user action based at least in part on the response. Other devices, systems, and methods are disclosed.

Claims (40)

1. A method, comprising:

receiving sensor glucose data representative of a blood glucose level of a user;

monitoring the sensor glucose data while a basal rate of insulin is being delivered to the user;

comparing the sensor glucose data to a target low glucose level;

determining a rate of change of the blood glucose level of the user from the sensor glucose data;

generally continuously monitoring the rate of change;

determining based on the monitoring of the rate of change that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level due to the basal rate of insulin being delivered to the user;

providing a notification indicating the risk of going below the target low glucose level.

2. The method of claim 1 , wherein providing the notification indicating the risk of going below the target low glucose level includes providing a message relating to a corrective action responsive to the risk of going below the target low glucose level.

3. The method of claim 2 , wherein the corrective action is a recommendation to ingest carbohydrates.

4. The method of claim 1 , further comprising implementing a corrective action in response to the risk of going below the target low glucose level.

5. The method of claim 4 , wherein the implemented corrective action is providing a recommendation to ingest carbohydrates.

6. The method of claim 1 , wherein determining that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level includes applying one or more rules to the rate of change.

7. The method of claim 1 , further comprising presenting a recommendation to reduce the basal rate of insulin to the user.

8. A method, comprising:

receiving sensor glucose data representative of a blood glucose level of a user;

monitoring the sensor glucose data while a basal rate of insulin is being delivered to the user;

comparing the sensor glucose data to a target low glucose level;

determining a rate of change of the blood glucose level of the user from the sensor glucose data;

generally continuously monitoring the rate of change;

determining, based on the monitoring of the rate of change that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level due to the basal rate of insulin being delivered to the user; and

implementing a corrective action in response to the risk of going below the target low glucose level.

9. The method of claim 8 , wherein the implemented corrective action is providing a recommendation to ingest carbohydrates.

10. The method of claim 8 , further comprising providing a notification on a user interface relating to the risk of going below the target low glucose level.

11. The method of claim 10 , wherein providing a notification relating to the risk of going below the target low glucose level includes providing a message relating to the corrective action.

12. The method of claim 11 , wherein the corrective action is a recommendation to ingest carbohydrates.

13. The method of claim 12 , wherein determining that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level includes applying one or more rules to the rate of change.

14. The method of claim 8 , further comprising presenting a recommendation to reduce the basal rate of insulin to the user.

15. A method, comprising:

receiving sensor glucose data representative of a blood glucose level of a user;

comparing the sensor glucose data to a target low glucose level;

determining a rate of change of the blood glucose level of the user from the sensor glucose data;

generally continuously monitoring the rate of change;

determining based on the monitoring of the rate of change that a future glucose level of the user is likely to be below the target low glucose level;

providing a notification indicating the future glucose level is likely to be below the target low glucose level.

16. The method of claim 15 , wherein providing a notification that the future glucose level is likely to be below the target low glucose level includes providing a message relating to a corrective action.

17. The method of claim 16 , wherein the corrective action is a recommendation to ingest carbohydrates.

18. The method of claim 15 , further comprising implementing a corrective action in response to the future glucose level being likely to be below the target low glucose level.

19. The method of claim 18 , wherein the implemented corrective action is providing a recommendation to ingest carbohydrates.

20. The method of claim 15 , further comprising presenting a recommendation to reduce the basal rate of insulin to the user.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2024
From: BLOOMQUIST, MICHAEL
To: SMITHS MEDICAL MD, INC.
Reel/Frame 068754/0342 →
MERGER Recorded Oct 1, 2024
From: SMITHS MEDICAL MD, INC.
To: SMITHS MEDICAL ASD, INC.
Reel/Frame 068754/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2024
From: SMITHS MEDICAL ASD, INC.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 068754/0533 →
Continuity (7)
Continuation 17715735 · Apr 7, 2022
Continuation 16560555 · Sep 4, 2019
Continuation 15830415 · Dec 4, 2017
Continuation In Part 14187414 · Feb 24, 2014
Continuation 13465570 · May 7, 2012
Division 11755480 · May 30, 2007
Related Publication 20240245326A1 · Jul 25, 2024
References Cited (2)
US 11986292B2 · Blomquist · 2024 [cited by examiner]
US 20050038332A1 · Saidara · 2005 [cited by examiner]